Evidence map›Paper›PMID 29412762›Full record

ArticleSLAS technology2018

Quantitative Live-Cell Confocal Imaging of 3D Spheroids in a High-Throughput Format.

Elizabeth Leary, Claire Rhee, Benjamin T Wilks, Jeffrey R Morgan

Abstract read
In one paragraph

Article in SLAS technology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Parallel and High Throughput Reaction Monitoring with Computer Vision.Angewandte Chemie (International ed. in English) · 2025
    Article
  8. Cell viability imaging in tumor spheroidsChemical communications (Cambridge, England) · 2024
    Article
  9. Article
  10. Development of a human liver microphysiological coculture system for higher throughput chemical safety assessment.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Three-Dimensional Spheroids for Cancer Research.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elizabeth Leary1 Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI, USA.
Claire Rhee1 Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI, USA.
Benjamin T Wilks1 Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI, USA.
Jeffrey R Morgan1 Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI, USA.

Funding

Human 3D Microtissues for Toxicity Testing via Integrated Imaging, Molecular and Functional AnalysesU01ES028184 · NIEHS · BROWN UNIVERSITY · PI BOEKELHEIDE, KIM, MORGAN, JEFFREY R · 2017 to 2021
$3.8M
NIEHS NIH HHS U01 ES028184
6 · The paper itself

Abstract

Accurately predicting the human response to new compounds is critical to a wide variety of industries. Standard screening pipelines (including both in vitro and in vivo models) often lack predictive power. Three-dimensional (3D) culture systems of human cells, a more physiologically relevant platform, could provide a high-throughput, automated means to test the efficacy and/or toxicity of novel substances. However, the challenge of obtaining high-magnification, confocal z stacks of 3D spheroids and understanding their respective quantitative limitations must be overcome first. To address this challenge, we developed a method to form spheroids of reproducible size at precise spatial locations across a 96-well plate. Spheroids of variable radii were labeled with four different fluorescent dyes and imaged with a high-throughput confocal microscope. 3D renderings of the spheroid had a complex bowl-like appearance. We systematically analyzed these confocal z stacks to determine the depth of imaging and the effect of spheroid size and dyes on quantitation. Furthermore, we have shown that this loss of fluorescence can be addressed through the use of ratio imaging. Overall, understanding both the limitations of confocal imaging and the tools to correct for these limits is critical for developing accurate quantitative assays using 3D spheroids.

Indexed as

Cell Line, TumorFluorescent DyesHigh-Throughput Screening AssaysHumansMicroscopy, ConfocalOrgan Culture TechniquesSpheroids, CellularFluorescent Dyesdata analysisfabricationhigh-throughput screeningHTS

Identifiers

PMID29412762
PMCPMC5962438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.